Clinical Trials Logo

Diabetes Mellitus, Type 2 clinical trials

View clinical trials related to Diabetes Mellitus, Type 2.

Filter by:

NCT ID: NCT06176703 Recruiting - Clinical trials for Diabetes Mellitus, Type 2

Mobile Application for Self-Management of Type 2 Diabetes Mellitus

Start date: November 22, 2023
Phase: N/A
Study type: Interventional

The goal of this Randomized Controlled Trial is to study the effect of mobile Application on glycemic control of type2 diabetes mellitus. The main questions aim to answer are: - The effect of mobile application on glycemic control and quality of life of diabetes mellitus patients - The satisfaction of mobile application of diabetes mellitus patients who used it Participants will be received education about diabetes mellitus and separated into two groups, intervention group(using mobile application) and control group(not using mobile application but also receive standard treatment of diabetes mellitus. Researchers will compare intervention group to control group about glycemic control including HbA1c, complications of diabetes mellitus etc. and quality of life.

NCT ID: NCT06173934 Recruiting - Diabetes Clinical Trials

The Effect of Gastric Emptying on Blood Glucose Profile of Type 1 Diabetes Mellitus and Its Therapeutic Strategies

Start date: December 1, 2023
Phase: N/A
Study type: Interventional

Establish a cohort study to describe the characteristics of gastric emptying in patients with type 1 diabetes, and adjust the timing of insulin injection during meals to improve blood glucose fluctuations according to the speed of gastric emptying.

NCT ID: NCT06171230 Recruiting - Diabetes Mellitus Clinical Trials

Eye Movement Desensitization and Reprocessing (EMDR) as a Treatment for Chronic Painful Diabetic Peripheral Neuropathy

EMDR4CPDN
Start date: March 1, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to investigate the effectiveness of Eye Movement Desensitization and Reprocessing (EMDR) therapy in reducing pain intensity in individuals with chronic painful diabetic neuropathy (PDN). The main questions it aims to answer are: 1. Does EMDR therapy significantly reduce pain intensity in individuals with chronic PDN? 2. What is the impact of EMDR therapy on secondary outcomes, specifically anxiety, sleep disturbances, and personalized pain-related limitations? Additionally, the study will explore the correlation between pain scores and symptoms of post-traumatic stress disorder (PTSD) in individuals with chronic PDN. Participants will undergo EMDR therapy sessions, focusing on the processing of emotionally charged pain-related events and addressing the pain itself. Main tasks for participants include active engagement in EMDR therapy sessions. Treatment outcomes, including changes in pain intensity, anxiety levels, sleep quality, and personalized pain-related limitations, will be monitored throughout the study.

NCT ID: NCT06170515 Recruiting - Diabetes Clinical Trials

BGM and HbA1c POC Device Evaluation

Start date: April 3, 2023
Phase: N/A
Study type: Interventional

This study aims to assess analytical performance of four BGMs and four HbA1c POC devices in comparison to suitable comparator or reference methods, with the view to evaluate performance in the hands of trained users, as well as intended users who are unfamiliar with the system (lay users, for BGMs only). System usability will also be assessed for all BGMs (including lancing devices) and HbA1c devices.

NCT ID: NCT06156124 Recruiting - Diabetes Clinical Trials

The Role of Family and Individual Factors in Going Through Adolescence - Perspective of a Healthy Child.

Start date: June 13, 2023
Phase:
Study type: Observational

The goal of this observational study is to investigate the specificity of the growing up process in young people with disabled siblings. The functioning of adolescents with disabled siblings as a person growing up in three environments will be examined: family, peers and school. The main questions it aims to answer are: - Does having a disabled sibling influence the functioning of a healthy child in the family system? - Do siblings of disabled children show a higher level of maturity than their peers with properly developing siblings? - Does having a disabled sibling modify a child's functioning among peers? - Does having a disabled sibling modify healthy adolescent's educational experience? - Is there a greater risk of psychological disorders among siblings of disabled children than among siblings of normally developing children? The 160 participants' dyads will take part in the study: healthy adolescent having disabled sibling and one of his/her parents. The parents' participation is necessary to assess the presence of possible internalizing and externalizing disorders among adolescents taking part in the study. The healthy adolescent will be filling out questionnaires regarding the remaining studied variables: functioning in the family - siblings relations, parental attitudes; at school - school achievement, extracurricular activities; relations with peers - time spending with peers, number of friends, as well as the growing up process trajectory - parentification and the way of going through an adolescent crisis. Researchers will compare four groups (40 dyads in each group): three groups of adolescents having disabled sibling 1) intellectual disability, 2) motor disability, 3) chronic somatic disease, and 4) control group - healthy adolescent having sibling without any disability, to see if they differ from each other referring to the studied variables.

NCT ID: NCT06152887 Recruiting - Clinical trials for Diabetes Mellitus, Type 1

Noninvasive Cortical Neurostimulation For Diabetic Neuropathic Pain

Start date: August 1, 2023
Phase: N/A
Study type: Interventional

To investigate whether transcranial direct current stimulation can alleviate pain and sensory related disturbances in individuals with type 1 diabetes and peripheral neuropathy through neuromodulation of the CNS as compared to sham treatment.

NCT ID: NCT06150690 Recruiting - Diabetes Mellitus Clinical Trials

Study on Pancreatic Islets in Patients Undergoing (Partial) Pancreatectomy (PRECISE)

PRECISE
Start date: August 21, 2012
Phase:
Study type: Observational

The study investigates the mechanisms underlying the pathogenesis of diabetes by examining structural and functional properties of islets of Langerhans in pancreas specimen from patients undergoing (partial) pancreatectomy.

NCT ID: NCT06144593 Recruiting - Clinical trials for Diabetes Mellitus, Type 2

The Metabolic Impact of Intermittent Carbohydrate Restriction in Individuals With Type 2 Diabetes

INTERCARB
Start date: January 3, 2024
Phase: N/A
Study type: Interventional

The primary aim of this randomized cross-over intervention study is to investigate the effect of four weeks of intermittent carbohydrate restriction (alternating between two days of normal dietary intake and two days of carbohydrate restriction to 70-90 grams) on 24-hour average sensor glucose in individuals with type 2 diabetes compared with a four-week control period with normal dietary intake.

NCT ID: NCT06143449 Recruiting - Diabetes Mellitus Clinical Trials

Taiwan Diabetes Registry

Start date: October 1, 2015
Phase:
Study type: Observational [Patient Registry]

To Investigate the Risk Factors, Life Style and Treatments of the Microvascular Disease,Macrovascular Disease and Neuropathy in Patients With Diabetes.

NCT ID: NCT06143423 Recruiting - Clinical trials for Diabetes Mellitus, Type 2

A Clinical Trial of AP026 (TQA2226) for Injection in Adult Subjects.

Start date: May 24, 2023
Phase: Phase 1
Study type: Interventional

This study was a randomized, double-blind, placebo-controlled phase I clinical trial of AP026 (TQA2226) for injection in adult healthy subjects, which planned to recruit 74 healthy subjects. The main purpose was to evaluate the safety and tolerance of AP026 (TQA2226) for injection after single and multiple doses in healthy subjects.